STERIS’ (TSE:STE – Free Report) – Investment analysts at Cormark reduced their FY2024 earnings estimates for shares of STERIS’ in a note issued to investors on Tuesday, November 5th. Cormark analyst B. Watson now expects that the company will post earnings per share of $0.77 for the year, down from their previous forecast of $0.90.
STERIS’ (TSE:STE – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported C$0.14 EPS for the quarter, beating the consensus estimate of C$0.12 by C$0.02. The business had revenue of C$231.38 million during the quarter, compared to analysts’ expectations of C$226.20 million.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- Stock Sentiment Analysis: How it Works
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- What is a support level?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- 3 Small Caps With Big Return Potential
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
